Profile
Jonae R.
Barnes is currently SVP-Investor Relations & Corporate Communications at Atea Pharmaceuticals, Inc. since 2021.
Former positions include SVP-Investor Relations & Corporate Communications at Sumitomo Pharma America, Inc. from 2007 to 2009, VP-Investor Relations & Corporate Communications at Agenus, Inc., Head-Investor Relations at Idenix Pharmaceuticals LLC, and Senior VP-Investor Relations & Public Relations at Poxel SA. Education includes graduate studies at Boston University and undergraduate studies at Suffolk University.
Jonae Barnes active positions
| Companies | Position | Start |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Investor Relations Contact | 2021-01-18 |
Former positions of Jonae Barnes
| Companies | Position | End |
|---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Investor Relations Contact | 2009-11-30 |
| POXEL | Investor Relations Contact | - |
| AGENUS INC. | Investor Relations Contact | - |
| IDENIX PHARMACEUTICALS INC | Investor Relations Contact | - |
Training of Jonae Barnes
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Agenus, Inc.
Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and other infectious diseases caused by hepatitis and human immunodeficiency virus | Health Technology |
Poxel SA
Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suffolk University
Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Jonae Barnes
















